Prescription Semaglutide for Weight Loss

---

 Semaglutide is a prescription medication, same ingredients in Ozempic, Wegovy, and Rybelsus.  Semaglutide belongs to a class of drugs called GLP-1 receptor agonists that is administered weekly.  The medication assists in regulating blood sugar levels in the body, metabolism, and appetite. 

 Semaglutide works by mimicking the action of a naturally occurring hormone in the body called GLP-1 (glucagon-like peptide-1). This hormone helps regulate blood sugar levels and appetite. When semaglutide is administered, it stimulates the release of insulin, reduces the production of glucagon, and slows down the emptying of the stomach. These actions collectively contribute to weight loss by promoting a feeling of fullness, reducing food intake, and improving insulin sensitivity. 

At Salish Shore Wellness we understand that there are many options of Semaglutide  available on the market today.  We want our clients to achieve their weight loss goals affordably, so we have chosen to only provide the most effective treatment options for our clients.  

We offer weekly subcutaneous self injection and weekly sublingual liquid treatment options. 

The majority of studies have shown that most people experience an average weight loss of 15% of their body weight during the course of treatment.  Semaglutide does take time to work as doses typically start at 0.25mg weekly, and are increased monthly until full dose is reached.  Initially, most clients notice changes in their body and figure, then experience measurable weight loss as they continue treatment.  These results are  typical of clients who only take prescription semaglutide, with no life style changes.  Increasing activity and making changes to your diet, compliment and enhance treatment for the most effective weight loss journey.   Adding increased activity and balanced meals to your weight loss treatment can increase average weight loss to 20% or more of your body weight. 

Semaglutide has been FDA approved and prescribed for over 15 years as a treatemnt option for type 2 diabetes, there has been significant research and development into the use of Semaglutide.   In 2021 the FDA approved Semaglutide as a treatment option for weight loss.  As of July 2023, almost 58 million Americans take Semaglutide weekly. 

Like most prescribed medications, Semaglutide does have side effects.  Less than 40% of those who take Semaglutide experience side effects, mainly during the first weeks of treatment.  Typical side effects during the first weeks of treatment are stomach/gastrointestinal issues.  These can be greatly mitigated by avoiding heavy or greasy food, deep fried food, high sugar food, and overeating.